FDA Approves CLOMID — Cosette Pharmaceuticals, Inc.

# FDA Approves Clomiphene Citrate Generic for Cosette Pharmaceuticals Cosette Pharmaceuticals, Inc. received FDA approval for its generic version of Clomid (clomiphene citrate), an oral fertility medication, potentially allowing the company to capture market share in the competitive women's health pharmaceutical segment as patent protections on the branded drug expired. The approval of clomiphene citrate is expected to provide more affordable treatment options for patients while opening new revenue opportunities for Cosette in the fertility drug market.